Onconetix ONCO
NASDAQ ONCO
$0.65 -0.02 (-2.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Onconetix (ONCO) Receivables - Net (2023 - 2026)

Onconetix (ONCO) posted quarterly Receivables - Net of $43725.0 for Q1 2026, up 168.37% year-over-year from $16293.0 in Q1 2025, and down 85.42% quarter-over-quarter from $300000.0 in Q4 2025.

Onconetix (ONCO) Receivables - Net (2023 - 2026) Analysis & Trends

Onconetix (ONCO) has reported Receivables - Net for 4 consecutive years, with $43725.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Receivables - Net rose 168.37% year-over-year to $43725.0; the TTM figure through Mar 2026 stood at $43725.0 (up 168.37% YoY), while the FY2025 annual figure was $300000.0, up 900.0% from the prior year.
  • Receivables - Net declined to $43725.0 in Q1 2026 per ONCO's latest filing, from $300000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $300000.0 in Q4 2025 and bottomed at $3000.0 in Q3 2025.
  • Historically, Receivables - Net has averaged $85006.2 across 4 years, with a median of $36862.5 in 2024.
  • On a YoY basis, Receivables - Net climbed as much as 900.0% in 2025 and fell as far as 96.94% in 2025.
  • Onconetix's Receivables - Net stood at $149731.0 in 2023, then sank by 79.96% to $30000.0 in 2024, then surged by 900.0% to $300000.0 in 2025, then tumbled by 85.42% to $43725.0 in 2026.
  • Business Quant data shows ONCO's Receivables - Net at $43725.0 in Q1 2026, $300000.0 in Q4 2025, and $3000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Onconetix 1.44 Mn -4.50 Mn 4,303.00

Historic Data

Download Data
DateValue
Jun 30, 2026 2,351.00
Jun 30, 2026 2,351.00
Mar 31, 2026 43,725.00
Mar 31, 2026 43,725.00
Dec 31, 2025 300,000.00
Dec 31, 2025 300,000.00
Sep 30, 2025 3,000.00
Sep 30, 2025 3,000.00
Jun 30, 2025 12,000.00
Jun 30, 2025 12,000.00
Mar 31, 2025 16,293.00
Mar 31, 2025 16,293.00
Dec 31, 2024 30,000.00
Dec 31, 2024 30,000.00
Sep 30, 2024 98,000.00
Sep 30, 2024 98,000.00
Jun 30, 2024 171,313.00
Jun 30, 2024 171,313.00
Mar 31, 2024 26,000.00
Mar 31, 2024 26,000.00